XML 89 R2.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Consolidated Statements of Income (USD $)
In Millions, except Per Share data
3 Months Ended 6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
Net Sales $ 16,046 $ 13,618 $ 30,779 $ 27,035
Cost of sales 13,551 11,580 25,668 23,121
Research and development expenses 411 407 811 814
Selling, general and administrative expenses 695 648 1,395 1,310
Amortization of intangibles 125 125 248 253
Restructuring charges 0 13 0 29
Acquisition and integration related expenses 0 37 31 63
Equity in earnings of nonconsolidated affiliates 291 244 589 548
Sundry income (expense) - net 80 95 (369) 178
Interest income 10 10 17 17
Interest expense and amortization of debt discount 328 367 705 743
Income Before Income Taxes 1,317 790 2,158 1,445
Provision for income taxes 240 131 360 234
Net Income 1,077 659 1,798 1,211
Net income attributable to noncontrolling interests 10 8 21 9
Net Income attributable to The Dow Chemical Company 1,067 651 1,777 1,202
Preferred stock dividends 85 85 170 170
Net Income Available for The Dow Chemical Company Common Stockholders 982 566 1,607 1,032
Per Common Share Data:        
Earnings per common share - basic $ 0.84 $ 0.50 $ 1.39 $ 0.92
Earnings per common share - diluted $ 0.84 $ 0.50 $ 1.37 $ 0.91
Common stock dividends declared per share of common stock $ 0.25 $ 0.15 $ 0.40 $ 0.30
Weighted-average common shares outstanding - basic 1,149.6 1,125.4 1,144.6 1,121.4
Weighted-average common shares outstanding - diluted 1,160.9 1,141.6 1,156.2 1,138.3
Depreciation 526 571 1,085 1,162
Capital Expenditures $ 564 $ 397 $ 969 $ 691